Therapeutic Asset Ratings

278 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Tucatinib Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Tucatinib Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Tucatinib Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Veliparib Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Veliparib Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Veliparib Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Vepdegestrant Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Vepdegestrant Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Vepdegestrant Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Vinorelbine Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Vinorelbine Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
vv1 Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
vv1 Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
vv1 Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Zanidatamab Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Zanidatamab Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Zanidatamab Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trastuzumab Duocarmazine HER2 Positive Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (52)
Trebananib Breast Neoplasm	QuantumLeap Healthcare Collaborative	P2	CCC (52)
Tucatinib Her2-Receptor Negative Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (52)
Zanidatamab Her2-Receptor Negative Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (52)
ARX 788 TNBC - Triple-Negative Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (51)
Dan-222 Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (51)
Encequidar Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (51)
Fianlimab Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (51)

Showing 101 to 125 of 278 assets

PreviousPage 5 of 12Next